(In the Media)‘Pharmaceutical Industry Crisis: the industry’s strategy for growth and survival- working in cooperation with healthcare providers to advance medical and pharmaceutical schools’’ (Monthly Mix, September 2014)
date : 9/1/2014
■‘Pharmaceutical Industry Crisis: the industry’s strategy for growth and
survival- working in cooperation with healthcare providers to advance
medical and pharmaceutical schools’’
(Monthly Mix, September 2014)
This article features an interview with Toshio Miyata, HGPI Executive Director.
(Monthly Mix, September 2014)
This article features an interview with Toshio Miyata, HGPI Executive Director.
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
